Bronchogen 20mg

Bronchogen (Ala-Glu-Asp-Leu) is a tetrapeptide bioregulator originally developed by the St Petersburg Institute of Bioregulation and Gerontology. As a short peptide bioregulator, it is composed of four amino acids — alanine, glutamic acid, aspartic acid, and leucine — and is believed to interact selectively with bronchopulmonary tissue at a genetic level, potentially influencing gene expression within respiratory epithelial cells.

In research settings, Bronchogen has been investigated for its putative role in supporting the structural and functional integrity of lung tissue. Studies have explored its potential to stimulate cellular repair mechanisms within the bronchi and bronchioles, making it of interest in age-related pulmonary decline research, tissue regeneration models, and investigations into chronic respiratory conditions.

As a peptide bioregulator, Bronchogen is thought to operate via epigenetic mechanisms — binding to DNA regulatory regions and modulating protein synthesis in a tissue-specific manner. This targeted activity profile makes it a valuable tool for researchers studying respiratory physiology, cellular ageing, and peptide-based therapeutic approaches.

Each vial contains 20mg of Bronchogen supplied as a lyophilised powder with a purity of >98% as verified by HPLC. Molecular formula: C₁₈H₃₀N₄O₉. Molecular weight: 462.45 g/mol. CAS: 135319-93-6. Store at -20°C, protected from light and moisture.

For research purposes only. Not for human use.